Patents by Inventor Kimberly Shields-Tuttle

Kimberly Shields-Tuttle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
    Publication number: 20240002494
    Abstract: Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.
    Type: Application
    Filed: June 16, 2023
    Publication date: January 4, 2024
    Inventors: Jewel Johanns, Katherine Li, Colleen Marano, Richard Strauss, Hongyan Zhang, Christopher O'Brien, Omoniyi Adedokun, Kimberly Shields-Tuttle
  • Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
    Publication number: 20210253690
    Abstract: Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.
    Type: Application
    Filed: February 12, 2021
    Publication date: August 19, 2021
    Inventors: Jewel Johanns, Katherine Li, Colleen Marano, Richard Strauss, Hongyan Zhang, Christopher O'Brien, Omoniyi Adedokun, Kimberly Shields-Tuttle
  • Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
    Publication number: 20210171622
    Abstract: Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.
    Type: Application
    Filed: February 11, 2021
    Publication date: June 10, 2021
    Inventors: Jewel Johanns, Katherine Li, Colleen Marano, Richard Strauss, Hongyan Zhang, Christopher O'Brien, Omoniyi Adedokun, Kimberly Shields-Tuttle
  • Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
    Publication number: 20210115129
    Abstract: Described are methods and compositions for clinically proven safe and effective treatment of ulcerative colitis according to the product label described herein, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.
    Type: Application
    Filed: October 16, 2020
    Publication date: April 22, 2021
    Inventors: Jewel Johanns, Katherine Li, Colleen Marano, Richard Strauss, Hongyan Zhang, Christopher O'Brien, Omoniyi Adedokun, Kimberly Shields-Tuttle
  • Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody
    Patent number: 10961307
    Abstract: Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: March 30, 2021
    Assignee: Janssen Biotech, Inc.
    Inventors: Jewel Johanns, Katherine Li, Colleen Marano, Richard Strauss, Hongyan Zhang, Christopher O'Brien, Omoniyi Adedokun, Kimberly Shields-Tuttle
  • Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
    Publication number: 20200095315
    Abstract: Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.
    Type: Application
    Filed: September 24, 2019
    Publication date: March 26, 2020
    Inventors: Jewel Johans, Katherine Li, Colleen Marano, Richard Strauss, Hongyan Zhang, Christopher O'Brien, Omoniyi Adedokun, Kimberly Shields-Tuttle